当前位置: X-MOL 学术J. Oral Microbiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lasting Gammaproteobacteria profile changes characterized hematological cancer patients who developed oral mucositis following conditioning therapy.
Journal of Oral Microbiology ( IF 4.5 ) Pub Date : 2020-05-13 , DOI: 10.1080/20002297.2020.1761135
Jean-Luc C Mougeot 1 , Micaela F Beckman 1 , Craig B Stevens 1 , Kathryn G Almon 1 , Darla S Morton 1 , Inger Von Bültzingslöwen 2 , Michael T Brennan 1 , Farah Bahrani Mougeot 1
Affiliation  

ABSTRACT

Background: Oral mucositis (OM) is a common side effect of conditioning therapy implemented before hematopoietic stem cell transplantation (HSCT). The role of oral microbiome in OM is not fully elucidated.

Objective: To determine oral microbiome profile changes post-conditioning in HSCT patients who developed moderate OM, or mild to no OM.

Design: Patient groups were: Muc0-1 with OM-score = 0–1 (43 paired samples) and Muc2 with WHO OM-score = 2 (36 paired samples). Bacterial DNA was isolated from oral samples (saliva, swabs of buccal mucosa, tongue, and supragingival plaque) at pre-conditioning (T0), post-conditioning mucositis onset (TMuc), and one-year post-conditioning (TYear). 16S-rRNA gene next-generation sequencing was used to determine the relative abundance (RA) of >700 oral species. Alpha-diversity, beta-diversity and linear discriminant analyses (LDA) were performed Muc2 versus Muc0-1.

Results: Muc2 oral microbiome alpha- and beta-diversity differed between T0 and TMuc. Muc2 alpha-diversity and Muc0-1 beta-diversity did not differ between T0 and TYear. T0 to TMuc LDA scores were significant in Muc2 for Gammaproteobacteria. For Muc2 patients, the average RA decreased for Haemophilus parainfluenza, a species known as mucosal surfaces protector, but increased for Escherichia-Shigella genera.

Conclusions: Post-conditioning OM might contribute to long-term oral microbiome changes affecting Gammaproteobacteria, in HSCT patients.



中文翻译:

经调节治疗后出现口腔粘膜炎的血液癌症患者的特征是伽玛变形菌谱发生持久变化。

摘要

背景:口腔粘膜炎(OM)是造血干细胞移植(HSCT)前进行的调理治疗的常见副作用。口腔微生物组在 OM 中的作用尚未完全阐明。

目的:确定出现中度 OM 或轻度至无 OM 的 HSCT 患者在调理后口腔微生物组特征的变化。

设计:患者组为:Muc0-1,OM 评分 = 0–1(43 个配对样本),Muc2,WHO OM 评分 = 2(36 个配对样本)。在预处理 (T 0 )、处理后粘膜炎发作 (T Muc ) 和处理一年后 (T Year ) 时从口腔样本(唾液、颊粘膜拭子、舌头和龈上菌斑)中分离细菌 DNA )。16S-rRNA基因新一代测序用于确定 > 700 个口腔物种的相对丰度 (RA)。对 Muc2与Muc0-1进行α-多样性、β-多样性和线性判别分析 (LDA) 。

结果: T 0和 T Muc之间Muc2 口腔微生物组αβ多样性不同。Muc2 α多样性和 Muc0-1 β多样性在 T 0和 T Year之间没有差异。T 0至 T Muc LDA 评分在 Muc2 中对于Gammaproteobacteria具有显着性。对于 Muc2 患者,副流感嗜血杆菌(一种被称为粘膜表面保护者的物种)的平均 RA 降低,但埃希氏菌-志贺菌属的平均 RA 增加。

结论:后处理 OM 可能会导致HSCT 患者口腔微生物群的长期变化,从而影响γ 变形菌。

更新日期:2020-05-13
down
wechat
bug